IBDEI0HK ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,7864,0)
 ;;=L20.81^^55^531^8
 ;;^UTILITY(U,$J,358.3,7864,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7864,1,3,0)
 ;;=3^Atopic neurodermatitis
 ;;^UTILITY(U,$J,358.3,7864,1,4,0)
 ;;=4^L20.81
 ;;^UTILITY(U,$J,358.3,7864,2)
 ;;=^5009108
 ;;^UTILITY(U,$J,358.3,7865,0)
 ;;=L20.0^^55^531^9
 ;;^UTILITY(U,$J,358.3,7865,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7865,1,3,0)
 ;;=3^Besnier's prurigo
 ;;^UTILITY(U,$J,358.3,7865,1,4,0)
 ;;=4^L20.0
 ;;^UTILITY(U,$J,358.3,7865,2)
 ;;=^5009107
 ;;^UTILITY(U,$J,358.3,7866,0)
 ;;=L20.82^^55^531^41
 ;;^UTILITY(U,$J,358.3,7866,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7866,1,3,0)
 ;;=3^Flexural eczema
 ;;^UTILITY(U,$J,358.3,7866,1,4,0)
 ;;=4^L20.82
 ;;^UTILITY(U,$J,358.3,7866,2)
 ;;=^5009109
 ;;^UTILITY(U,$J,358.3,7867,0)
 ;;=L20.84^^55^531^52
 ;;^UTILITY(U,$J,358.3,7867,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7867,1,3,0)
 ;;=3^Intrinsic (allergic) eczema
 ;;^UTILITY(U,$J,358.3,7867,1,4,0)
 ;;=4^L20.84
 ;;^UTILITY(U,$J,358.3,7867,2)
 ;;=^5009111
 ;;^UTILITY(U,$J,358.3,7868,0)
 ;;=L20.89^^55^531^7
 ;;^UTILITY(U,$J,358.3,7868,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7868,1,3,0)
 ;;=3^Atopic Dermatitis NEC
 ;;^UTILITY(U,$J,358.3,7868,1,4,0)
 ;;=4^L20.89
 ;;^UTILITY(U,$J,358.3,7868,2)
 ;;=^5009112
 ;;^UTILITY(U,$J,358.3,7869,0)
 ;;=L25.5^^55^531^27
 ;;^UTILITY(U,$J,358.3,7869,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7869,1,3,0)
 ;;=3^Contact Dermatitis d/t Plants,Unspec
 ;;^UTILITY(U,$J,358.3,7869,1,4,0)
 ;;=4^L25.5
 ;;^UTILITY(U,$J,358.3,7869,2)
 ;;=^5009142
 ;;^UTILITY(U,$J,358.3,7870,0)
 ;;=L56.0^^55^531^33
 ;;^UTILITY(U,$J,358.3,7870,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7870,1,3,0)
 ;;=3^Drug phototoxic response
 ;;^UTILITY(U,$J,358.3,7870,1,4,0)
 ;;=4^L56.0
 ;;^UTILITY(U,$J,358.3,7870,2)
 ;;=^5009214
 ;;^UTILITY(U,$J,358.3,7871,0)
 ;;=L56.1^^55^531^32
 ;;^UTILITY(U,$J,358.3,7871,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7871,1,3,0)
 ;;=3^Drug photoallergic response
 ;;^UTILITY(U,$J,358.3,7871,1,4,0)
 ;;=4^L56.1
 ;;^UTILITY(U,$J,358.3,7871,2)
 ;;=^5009215
 ;;^UTILITY(U,$J,358.3,7872,0)
 ;;=L56.2^^55^531^120
 ;;^UTILITY(U,$J,358.3,7872,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7872,1,3,0)
 ;;=3^Photocontact dermatitis [berloque dermatitis]
 ;;^UTILITY(U,$J,358.3,7872,1,4,0)
 ;;=4^L56.2
 ;;^UTILITY(U,$J,358.3,7872,2)
 ;;=^5009216
 ;;^UTILITY(U,$J,358.3,7873,0)
 ;;=L25.9^^55^531^28
 ;;^UTILITY(U,$J,358.3,7873,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7873,1,3,0)
 ;;=3^Contact Dermatitis,Unspec Cause
 ;;^UTILITY(U,$J,358.3,7873,1,4,0)
 ;;=4^L25.9
 ;;^UTILITY(U,$J,358.3,7873,2)
 ;;=^5133647
 ;;^UTILITY(U,$J,358.3,7874,0)
 ;;=L27.0^^55^531^45
 ;;^UTILITY(U,$J,358.3,7874,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7874,1,3,0)
 ;;=3^Gen skin eruption d/t drugs/meds taken internally
 ;;^UTILITY(U,$J,358.3,7874,1,4,0)
 ;;=4^L27.0
 ;;^UTILITY(U,$J,358.3,7874,2)
 ;;=^5009144
 ;;^UTILITY(U,$J,358.3,7875,0)
 ;;=L27.1^^55^531^53
 ;;^UTILITY(U,$J,358.3,7875,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7875,1,3,0)
 ;;=3^Loc skin eruption d/t drugs/meds taken internally
 ;;^UTILITY(U,$J,358.3,7875,1,4,0)
 ;;=4^L27.1
 ;;^UTILITY(U,$J,358.3,7875,2)
 ;;=^5009145
 ;;^UTILITY(U,$J,358.3,7876,0)
 ;;=L71.8^^55^531^136
 ;;^UTILITY(U,$J,358.3,7876,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7876,1,3,0)
 ;;=3^Rosacea NEC
 ;;^UTILITY(U,$J,358.3,7876,1,4,0)
 ;;=4^L71.8
 ;;^UTILITY(U,$J,358.3,7876,2)
 ;;=^5009275
 ;;^UTILITY(U,$J,358.3,7877,0)
 ;;=L71.0^^55^531^119
 ;;^UTILITY(U,$J,358.3,7877,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7877,1,3,0)
 ;;=3^Perioral dermatitis
